secwatch.observer — SEC 8-K summary
======================================

Issuer:     Assertio Holdings, Inc. (ASRT)
CIK:        0001808665
Form:       8-K
Filed at:   2026-06-16T20:43:51+00:00
Accession:  0001104659-26-074619
Event type: m_and_a
Sentiment:  neutral
Materiality: 1.00
Item codes: 1.01, 2.01, 2.04, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Assertio completes Zydus merger at $23.50/share; notes conversion set at $382.58 per $1,000
--------------------------------------------------------------------------------

- Merger completed June 16; shareholders receive $23.50 per share cash; stock delisted from Nasdaq.
- 66.32% of shares tendered; all conditions satisfied; company now wholly owned by Zydus Lifesciences.
- Board replaced: Ravi Yadavar and Punit Patel named directors; prior directors and officers resigned.
- Holders of $40M 6.5% convertible notes due 2027 can elect repurchase at 100% plus accrued interest by July 16, or convert into $382.58 cash per $1,000 principal.
- First Supplemental Indenture executed; conversion rate adjusted to cash-only based on $23.50 merger consideration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808665/000110465926074619/0001104659-26-074619-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808665/000110465926074619/tm2617883d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-074619

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer